These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7387553)

  • 1. Bacterial infection in preterm infants during xanthine therapy for idiopathic apnoea of prematurity.
    Barr PA; O'Loughlin EV; Anderson DG
    Aust Paediatr J; 1980 Mar; 16(1):24-7. PubMed ID: 7387553
    [No Abstract]   [Full Text] [Related]  

  • 2. The xanthine treatment of apnea of prematurity.
    Lucey JF
    Pediatrics; 1975 May; 55(5):584-6. PubMed ID: 1128983
    [No Abstract]   [Full Text] [Related]  

  • 3. Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies.
    Jones RA; Baillie E
    Arch Dis Child; 1979 Mar; 54(3):190-3. PubMed ID: 434904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic apnoea of prematurity treated with doxapram and aminophylline.
    Sagi E; Eyal F; Alpan G; Patz D; Arad I
    Arch Dis Child; 1984 Mar; 59(3):281-3. PubMed ID: 6424586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal aminophylline in the management of apnoea of prematurity.
    Lyon AJ; McIntosh N
    Arch Dis Child; 1985 Jan; 60(1):38-41. PubMed ID: 3970566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep and aminophylline treatment of apnea in preterm infants.
    Gabriel M; Witolla C; Albani M
    Eur J Pediatr; 1978 Jul; 128(3):145-9. PubMed ID: 668722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the efficacy and safety of aminophylline in treatment of apnea of prematurity in neonatal intensive care unit.
    Ye C; Miao C; Yu L; Dong Z; Zhang J; Mao Y; Lu X; Lyu Q
    Pediatr Neonatol; 2019 Feb; 60(1):43-49. PubMed ID: 29673564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminophylline versus doxapram in idiopathic apnea of prematurity: a double-blind controlled study.
    Eyal F; Alpan G; Sagi E; Glick B; Peleg O; Dgani Y; Arad I
    Pediatrics; 1985 Apr; 75(4):709-13. PubMed ID: 3982903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxapram in the treatment of idiopathic apnea of prematurity unresponsive to aminophylline.
    Alpan G; Eyal F; Sagi E; Springer C; Patz D; Goder K
    J Pediatr; 1984 Apr; 104(4):634-7. PubMed ID: 6707826
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma xanthine levels in premature infants treated for apnoea with theophylline.
    Hargreaves DB; Lealman GT; Mulley BA
    J Clin Hosp Pharm; 1983 Jun; 8(2):133-6. PubMed ID: 6875009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theophylline in treatment of apnoea of prematurity.
    Gupta JM; Mercer HP; Koo WW
    Aust Paediatr J; 1981 Dec; 17(4):290-1. PubMed ID: 7347217
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of theophylline on neurotransmitters in preterm infants with apnea.
    Bhat AM; Scanlon JW; Lavenstein B; Chuang L; Karoum F
    Clin Neuropharmacol; 1983 Mar; 6(1):71-4. PubMed ID: 6133614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxapram versus methylxanthine for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000075. PubMed ID: 10796115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in state in apneic pre-term infants receiving theophylline.
    Dietrich J; Krauss AN; Reidenberg M; Drayer DE; Auld PA
    Clin Pharmacol Ther; 1978 Oct; 24(4):474-8. PubMed ID: 688737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term neurodevelopment outcome of caffeine versus aminophylline therapy for apnea of prematurity.
    Khurana S; Shivakumar M; Sujith Kumar Reddy GV; Jayashree P; Ramesh Bhat Y; Lewis LES
    J Neonatal Perinatal Med; 2017; 10(4):355-362. PubMed ID: 29286928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen consumption in apneic premature infants after low-dose theophylline.
    Milsap RL; Krauss AN; Auld PA
    Clin Pharmacol Ther; 1980 Oct; 28(4):536-40. PubMed ID: 7408413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies surrounding xanthine therapy.
    Millar D; Schmidt B
    Semin Neonatol; 2004 Jun; 9(3):239-44. PubMed ID: 15050217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of theophylline in the treatment of apnea of prematurity.
    Sims ME; Yau G; Rambhatla S; Cabal L; Wu PY
    Am J Dis Child; 1985 Jun; 139(6):567-70. PubMed ID: 3890520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of theophylline use in Wolff-Parkinson-White syndrome.
    Agwunobi J; Abedin M; Young M; Beeram M; Sinkford S
    J Natl Med Assoc; 1996 Jul; 88(7):450-2. PubMed ID: 8764528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentration-effect relationship of theophylline in treatment of apnea in preterm infants.
    Lagercrantz H; Rane A; Tunell R
    Eur J Clin Pharmacol; 1980 Jul; 18(1):65-8. PubMed ID: 7398750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.